Tom Ferguson
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 9
- Pancreatic and Hepatic Oncology Research 2
-
- Renal cell carcinoma treatment 9
- Prostate Cancer Treatment and Research 2
- Co-authors
- Andrew Redfern (5 shared papers)Martin Gore (2 shared papers)Marine Gross‐Goupil (4 shared papers)Jae‐Lyun Lee (4 shared papers)Carla de Boer (1 shared paper)Piotr Tomczak (4 shared papers)James Larkin (1 shared paper)Piotr Sawrycki (4 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)BMJ Open (2 papers)British Journal of Cancer (1 paper)British Journal of Urology (1 paper)Therapeutic Advances in Medical Oncology (1 paper)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Tom Ferguson
18 papers receiving 155 citations
Peers
Comparison fields: 5 of 52
- Oncology 73
- Cancer Research 31
- Pulmonary and Respiratory Medicine 64
- Urology 7
- Surgery 46
Countries citing papers authored by Tom Ferguson
This map shows the geographic impact of Tom Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Ferguson more than expected).
Fields of papers citing papers by Tom Ferguson
This network shows the impact of papers produced by Tom Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Ferguson. The network helps show where Tom Ferguson may publish in the future.
Co-authors
The 25 scholars most cited alongside Tom Ferguson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 33 | |
| 2 | 2021 | 26 | |
| 3 | 2022 | 20 | |
| 4 | 2017 | 18 | |
| 5 | 1974 | 16 | |
| 6 | 2021 | 12 | |
| 7 | 2022 | 10 | |
| 8 | The no-nag, no-guilt, do-it-your-own-way guide to quitting smoking | 1988 | 4 |
| 9 | 2022 | 4 | |
| 10 | 2021 | 3 | |
| 11 | 2023 | 3 | |
| 12 | HER-2 and response to paclitaxel in node positive breast cancer | 2007 | 3 |
| 13 | 2010 | 2 | |
| 14 | 2021 | 2 | |
| 15 | 2022 | 2 | |
| 16 | A strategic approach for promoting access to clean energy development | 2006 | 1 |
| 17 | 2021 | 1 | |
| 18 | 2025 | 1 | |
| 19 | Deep Throttle Turbopump Technology Design Concepts | 2013 | 0 |
| 20 | 2016 | 0 |
About Tom Ferguson
Tom Ferguson is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Cancer Research, having authored 20 papers that have together received 161 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Cancer Immunotherapy and Biomarkers (9 papers), Bladder and Urothelial Cancer Treatments (7 papers), Renal and related cancers (4 papers), Cancer Genomics and Diagnostics (2 papers), Prostate Cancer Treatment and Research (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Urinary and Genital Oncology Studies (2 papers). The work is most often cited by research in Oncology (73 citations), Cancer Research (31 citations), Pulmonary and Respiratory Medicine (64 citations), Urology (7 citations) and Surgery (46 citations). Tom Ferguson has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Andrew Redfern, Martin Gore, Marine Gross‐Goupil, Jae‐Lyun Lee, Carla de Boer, Piotr Tomczak, James Larkin, Piotr Sawrycki, Se Hoon Park and Maggie James. Their work appears in journals such as Journal of Clinical Oncology, BMJ Open, British Journal of Cancer, British Journal of Urology and Therapeutic Advances in Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.